2 results
Approved WMORecruiting
The objective of the study is a prospective study to evaluate which type of TE shunt prosthesis is the most cost-effective.
Approved WMOCompleted
To evaluate the efficacy of romiplostim for the treatment of thrombocytopenia in subjects with international prognostic scoring system (IPSS) low or intermediate-1 risk MDS as measured by the number of clinically significant bleeding events.